Category: Firm News
DePuy Hip Recall Makes Some Experts Question FDA Medical Device Review Process
|
|
Last Modified
on
May 02, 2024
A recently released medical device study concludes that the FDA should “abandon” its present system for approving U.S. medical devices such as the DePuy Hip because it fails to ensure patient safety. Currently, the FDA employs a streamlined approach to approve medical device applications such as those for the beleaguered DePuy knee and hip parts… read more
Senate To Begin Investigation Of DePuy Hip Safety
|
|
Last Modified
on
May 02, 2024
This week the U.S Senate will begin its probe into medical device recalls and the connection between the massive DePuy Hip Replacement recall and the FDA’s role in “protecting patient safety as part of the medical device approval process.” The DePuy Hip was recalled after numerous reports of metal shards breaking off the hip replacement… read more
DePuy Hip Linked To Metal Poisoning
|
|
Last Modified
on
May 02, 2024
More and more claims concerning the troubled DePuy Hip continue to emerge. A recent article reveals that in addition to extreme pain from the faulty medical device, other symptoms related to metal poisoning occurred. According to one DePuy Hip patient – Tony Stauffer – discussed in the San Diego news, his hair started to fall… read more
Product Liability Claims Arising Out Of DePuy Hip Replacements
|
|
Last Modified
on
May 02, 2024
As reported in the Wall Street Journal – as the result of a loophole in the Food and Drug Administration’s regulation of medical implants – many potentially faulty hip implants are on the market. New drugs must undergo clinical trials before receiving FDA approval, however, if a medical implant resembles a product already on the… read more
Medical Malpractice Reform Should Focus On Patient Safety
|
|
Last Modified
on
May 02, 2024
Medical Malpractice reform has been receiving much attention recently with the introduction of H.R. 5, which seeks to impose national tort reform measures, including the imposition of caps on non-economic damages as well as potentially taking away the right to trial by jury in some medical malpractice cases. As New Mexico medical malpractice lawyers, we… read more
Depuy Hip Recall Cases Escalate
|
|
Last Modified
on
May 02, 2024
Every day more and more cases are reported of patients injured after being fitted with the Depuy hip – an artificial hip replacement. According to reports, metal shards may break off of the hip replacement and lodge themselves in patients’ bodies after being fitted. Although sometimes the problem can be resolved with subsequent surgery –… read more
Senator Questions Company’s Response To Paid Consultant’s Complaints About Zimmer Durom Cup
|
|
Last Modified
on
May 02, 2024
In a letter, previously posted on the WSJ website, to Zimmer CEO David Dvorak, Senator Charles Grassley raised questions regarding how the company responds to criticisms concerning joint replacement products, including the Zimmer Durom Cup (also known as the Zimmer Durom Acetabular Cup), by physicians who are paid company consultants. Grassley has a history of… read more
New Mexico Medical Device Law – Passing The MDSA Is Crucial To Patient Safety
|
|
Last Modified
on
May 02, 2024
The Medical Device Safety Act of 2009 (the “MDSA”) is one of this year’s top pieces of consumer rights legislation. This crucial legislation seeks to protect patients from dangerous and defective medical devices by reversing the effect of the Supreme Court’s ruling in Riegel v. Medtronic. Riegel provides blanket immunity from liability to some medical… read more
Zimmer NexGen Knee Recall Urged Due To Component Problems
|
|
Last Modified
on
May 02, 2024
Several physicians are urging a Zimmer NexGen Knee recall as the result of serious problems and component failures in the knee, requiring additional surgeries. The FDA has recalled some of the components following several lawsuits concerning the Zimmer NexGen CR-Flex knee failure rate. In fact, a prominent consultant for Zimmer recently went public stating that… read more
F.D.A. Orders More Studies On The Risks Associated With Transvaginal Mesh
|
|
Last Modified
on
May 02, 2024
As anticipated, last week the Food and Drug Administration (FDA) issued an order requiring more studies on the risks of transvaginal mesh by manufacturers. Transvaginal mesh – also referred to as vaginal mesh and pelvic mesh – has come under fire after years of reports linking serious injuries to the devices. In September, an F.D.A…. read more
Knowledge Experience Compassion Service 
